1. Home
  2. SVRA vs MCBS Comparison

SVRA vs MCBS Comparison

Compare SVRA & MCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRA
  • MCBS
  • Stock Information
  • Founded
  • SVRA 2007
  • MCBS 2006
  • Country
  • SVRA United States
  • MCBS United States
  • Employees
  • SVRA N/A
  • MCBS N/A
  • Industry
  • SVRA Biotechnology: Pharmaceutical Preparations
  • MCBS Major Banks
  • Sector
  • SVRA Health Care
  • MCBS Finance
  • Exchange
  • SVRA Nasdaq
  • MCBS Nasdaq
  • Market Cap
  • SVRA 528.3M
  • MCBS 709.2M
  • IPO Year
  • SVRA N/A
  • MCBS 2019
  • Fundamental
  • Price
  • SVRA $2.39
  • MCBS $29.35
  • Analyst Decision
  • SVRA Buy
  • MCBS Hold
  • Analyst Count
  • SVRA 5
  • MCBS 1
  • Target Price
  • SVRA $5.60
  • MCBS $34.00
  • AVG Volume (30 Days)
  • SVRA 1.4M
  • MCBS 50.1K
  • Earning Date
  • SVRA 08-11-2025
  • MCBS 07-22-2025
  • Dividend Yield
  • SVRA N/A
  • MCBS 3.07%
  • EPS Growth
  • SVRA N/A
  • MCBS 30.91
  • EPS
  • SVRA N/A
  • MCBS 2.58
  • Revenue
  • SVRA N/A
  • MCBS $143,775,000.00
  • Revenue This Year
  • SVRA N/A
  • MCBS $16.00
  • Revenue Next Year
  • SVRA N/A
  • MCBS $31.75
  • P/E Ratio
  • SVRA N/A
  • MCBS $11.28
  • Revenue Growth
  • SVRA N/A
  • MCBS 19.70
  • 52 Week Low
  • SVRA $1.89
  • MCBS $24.24
  • 52 Week High
  • SVRA $5.11
  • MCBS $36.15
  • Technical
  • Relative Strength Index (RSI)
  • SVRA 53.01
  • MCBS 57.73
  • Support Level
  • SVRA $1.98
  • MCBS $29.64
  • Resistance Level
  • SVRA $2.50
  • MCBS $30.13
  • Average True Range (ATR)
  • SVRA 0.17
  • MCBS 0.59
  • MACD
  • SVRA 0.05
  • MCBS 0.14
  • Stochastic Oscillator
  • SVRA 78.85
  • MCBS 68.95

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About MCBS MetroCity Bankshares Inc.

MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.

Share on Social Networks: